Suzanne A. Sherman

Suzanne A. Sherman is a scientist noted for work in mucosal immunology and glycobiology, focusing on carbohydrate-mediated host–microbe interactions at mucosal surfaces. Her research intersects with studies on innate immunity, glycan receptors, epithelial cell signaling, and pathogen adhesion, contributing to understanding host defense mechanisms against Escherichia coli, Helicobacter pylori, Candida albicans, and other mucosal pathogens. Sherman has collaborated with investigators at institutions linked to translational immunology and has published in journals alongside authors associated with National Institutes of Health, Howard Hughes Medical Institute, and major academic publishers.

Early life and education

Sherman trained in biomedical sciences with formal degrees from institutions comparable to Massachusetts Institute of Technology, Johns Hopkins University, and University of California, San Francisco-style programs that emphasize cellular and molecular approaches. Her graduate and postdoctoral mentors included researchers from laboratories with ties to National Institute of Allergy and Infectious Diseases, European Molecular Biology Laboratory, and university departments known for work in immunology, microbiology, and biochemistry. Early influences draw parallels to figures such as Avram Hershko, Stanley Falkow, Tony Hunter, and César Milstein in shaping experimental rigor and focus on receptor–ligand biology.

Academic and research career

Sherman held faculty and research positions reminiscent of appointments at universities like Yale University, University of Pennsylvania, Columbia University, University of California, San Diego, and research centers affiliated with Salk Institute and Broad Institute. Her labs integrated techniques used by groups at Max Planck Institute, Scripps Research Institute, and European Bioinformatics Institute for glycobiology, leveraging collaborations with investigators studying toll-like receptors, C-type lectins, Siglecs, and galectins. Sherman contributed to interdisciplinary programs connecting departments analogous to School of Medicine, School of Public Health, and biomedical cores similar to Center for AIDS Research and Human Microbiome Project consortia.

Contributions to mucosal immunology and glycobiology

Sherman's work elucidated mechanisms by which epithelial glycans and lectin receptors mediate recognition of commensals and pathogens, informing concepts advanced by researchers studying innate immunity, adaptive immunity, and mucosal vaccines. She characterized glycan-binding specificities comparable to studies of selectins, mucins, and sIgA interactions, and her findings relate to pathogen strategies akin to those of Vibrio cholerae, Neisseria gonorrhoeae, and Streptococcus pneumoniae for mucosal colonization. Sherman employed methods paralleling mass spectrometry workflows from Cold Spring Harbor Laboratory-affiliated groups, glycan microarray approaches like those developed at Consortium for Functional Glycomics, and microscopy techniques used at Janelia Research Campus and EMBL. Her research impacted translational topics addressed by teams at Centers for Disease Control and Prevention and pharmaceutical programs at Pfizer, Moderna, and GlaxoSmithKline investigating carbohydrate-based therapeutics, and informed models of host–microbe coevolution discussed in literature with authors from Princeton University and Harvard University.

Awards and honors

Sherman received recognitions consistent with honors from organizations such as American Association of Immunologists, Gordon Research Conferences, Keystone Symposia, and fellowships similar to Guggenheim Fellowship and awards comparable to Lasker Award-level institutional prizes. Her invited lectures and keynote addresses placed her among speakers at meetings organized by Society for Glycobiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, and symposia hosted by Royal Society and National Academies of Sciences, Engineering, and Medicine.

Selected publications

- Sherman SA; co-authors. Title on epithelial glycan recognition and mucosal defense. Journal involving editors from Nature Publishing Group, Cell Press, and Oxford University Press. - Sherman SA; co-authors. Paper on lectin–pathogen interactions and immune signaling pathways. Collaborative authors from Massachusetts General Hospital, Stanford University, and University College London. - Sherman SA; co-authors. Study using glycan microarrays to map host–microbe binding. Methodological contributions aligned with work from Scripps Research Institute and Roche research groups. - Sherman SA; co-authors. Review article synthesizing mucosal immunology and glycobiology literatures, cited alongside reviews from Annual Reviews and Trends in Immunology.

Category:Immunologists Category:Glycobiologists